Edinburgh Molecular Imaging (EMI) is a clinical-phase biotechnology company developing fluorescent imaging agents to improve medical procedures
Edinburgh Molecular Imaging (EMI) is a clinical-phase biotechnology company developing fluorescent imaging agents to improve medical procedures. The company creates injectable optical imaging agents that bind to specific biomarkers on diseased cells, allowing for real-time visualization of cancerous tissue during surgical procedures.